MET and rhabdomyosarcoma: In rhabdomyosarcoma miRNA-1 suppresses tumor growth by targeting the oncogene c-met [30] and in A549 lung cancer cells an over-expression of miRNA-1 sensitizes cells to the chemotherapeutic agent doxorubicin [29].